These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 9198452)

  • 1. [Shortened version of the Barcelona test (III): criterion validity with the ADAS-Cog].
    Peña-Casanova J; Meza M; Bertran-Serra I; Manero RM; Espel G; Martí A; Böhm P; Blesa R; Guardia J
    Neurologia; 1997 Mar; 12(3):117-9. PubMed ID: 9198452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The validity and reliability of the Turkish version of Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) in patients with mild and moderate Alzheimer's disease and normal subjects.
    Mavioglu H; Gedizlioglu M; Akyel S; Aslaner T; Eser E
    Int J Geriatr Psychiatry; 2006 Mar; 21(3):259-65. PubMed ID: 16477580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study of the Alzheimer's Disease Assessment Scale-Cognitive (ADAS-Cog) in an Icelandic elderly population.
    Hannesdóttir K; Snaedal J
    Nord J Psychiatry; 2002; 56(3):201-6. PubMed ID: 12079572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Validity of the Japanese version of Rivermead Behavioural Memory Test for evaluation of everyday memory function in patients with mild Alzheimer's disease].
    Matsuda A; Kazui H; Hirono N; Mori E
    No To Shinkei; 2002 Aug; 54(8):673-8. PubMed ID: 12355878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The characteristics of patients with uncertain/mild cognitive impairment on the Alzheimer disease assessment scale-cognitive subscale.
    Pyo G; Elble RJ; Ala T; Markwell SJ
    Alzheimer Dis Assoc Disord; 2006; 20(1):16-22. PubMed ID: 16493231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropsychometric tests in cross sectional and longitudinal studies - a regression analysis of ADAS - cog, SKT and MMSE.
    Ihl R; Grass-Kapanke B; Jänner M; Weyer G
    Pharmacopsychiatry; 1999 Nov; 32(6):248-54. PubMed ID: 10599935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical trials in Alzheimer's disease. Calculating Alzheimer's Disease Assessment Scale-cognitive subsection with the data from the consortium to establish a registry for Alzheimer's disease.
    Gillen TE; Gregg KM; Yuan H; Kurth MC; Krishnan KR
    Psychopharmacol Bull; 2001; 35(2):83-96. PubMed ID: 12397889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The need for a consensus in the use of assessment tools for Alzheimer's disease: the Feasibility Study (assessment tools for dementia in Alzheimer Centres across Europe), a European Alzheimer's Disease Consortium's (EADC) survey.
    Paulino Ramirez Diaz S; Gil Gregório P; Manuel Ribera Casado J; Reynish E; Jean Ousset P; Vellas B; Salmon E
    Int J Geriatr Psychiatry; 2005 Aug; 20(8):744-8. PubMed ID: 16035121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subjective memory complaints in Chinese subjects with mild cognitive impairment and early Alzheimer's disease.
    Lam LC; Lui VW; Tam CW; Chiu HF
    Int J Geriatr Psychiatry; 2005 Sep; 20(9):876-82. PubMed ID: 16116581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How well do the ADAS-cog and its subscales measure cognitive dysfunction in Alzheimer's disease?
    Benge JF; Balsis S; Geraci L; Massman PJ; Doody RS
    Dement Geriatr Cogn Disord; 2009; 28(1):63-9. PubMed ID: 19641319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Memory, language, and praxis in Alzheimer's disease: norms for outpatient clinical trial populations.
    Doraiswamy PM; Bieber F; Kaiser L; Connors K; Krishnan KR; Reuning-Scherer J; Gulanski B
    Psychopharmacol Bull; 1997; 33(1):123-8. PubMed ID: 9133763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening of mild cognitive impairment in Chinese older adults--a multistage validation of the Chinese abbreviated mild cognitive impairment test.
    Lam LC; Tam CW; Lui VW; Chan WC; Chan SS; Chiu HF; Leung T; Tham MK; Ho KS; Chan WM
    Neuroepidemiology; 2008; 30(1):6-12. PubMed ID: 18204291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conversion of amnestic Mild Cognitive Impairment to dementia of Alzheimer type is independent to memory deterioration.
    Rozzini L; Chilovi BV; Conti M; Bertoletti E; Delrio I; Trabucchi M; Padovani A
    Int J Geriatr Psychiatry; 2007 Dec; 22(12):1217-22. PubMed ID: 17562522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the Alzheimer's Disease Assessment Scale Cognitive Subscale and the Vascular Dementia Assessment Scale in differentiating elderly individuals with different degrees of white matter changes. The LADIS Study.
    Ylikoski R; Jokinen H; Andersen P; Salonen O; Madureira S; Ferro J; Barkhof F; van der Flier W; Schmidt R; Fazekas F; Scheltens P; Waldemar G; Salvadori E; Pantoni L; Inzitari D; Erkinjuntti T;
    Dement Geriatr Cogn Disord; 2007; 24(2):73-81. PubMed ID: 17565216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The TE4D-Cog: a new test for detecting early dementia in English-speaking populations.
    Mahoney R; Johnston K; Katona C; Maxmin K; Livingston G
    Int J Geriatr Psychiatry; 2005 Dec; 20(12):1172-9. PubMed ID: 16315149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Alzheimer's Disease Assessment Scale-Cognitive subscale: normative data for older adult controls.
    Graham DP; Cully JA; Snow AL; Massman P; Doody R
    Alzheimer Dis Assoc Disord; 2004; 18(4):236-40. PubMed ID: 15592137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Korean version of the Baylor Profound Mental Status Examination: a brief staging measure for patients with severe Alzheimer's disease.
    Na HR; Lee SH; Lee JS; Doody RS; Kim SY
    Dement Geriatr Cogn Disord; 2009; 27(1):69-75. PubMed ID: 19145080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Adaptation and normalization of the Alzheimer's disease Assessment Scale for Spain (NORMACODEM) (II)].
    Peña-Casanova J; Aguilar M; Santacruz P; Bertran-Serra I; Hernández G; Sol JM; Pujol A; Blesa R
    Neurologia; 1997 Feb; 12(2):69-77. PubMed ID: 9147454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Validity of the Spanish version of the Addenbrooke's Cognitive Examination for the diagnosis of dementia and to differentiate Alzheimer's disease and frontotemporal dementia].
    Sarasola D; de Luján-Calcagno M; Sabe L; Crivelli L; Torralva T; Roca M; García-Caballero A; Manes F
    Rev Neurol; 2005 Dec 16-31; 41(12):717-21. PubMed ID: 16355355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.